Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,931 | 758 | 98.7% |
| Education | $155.43 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,905 | 220 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,185 | 129 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,092 | 66 | $0 (2024) |
| Grifols USA, LLC | $729.07 | 42 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $510.96 | 22 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $482.62 | 41 | $0 (2020) |
| Electromed, Inc. | $476.50 | 45 | $0 (2024) |
| Genentech USA, Inc. | $438.94 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $370.66 | 18 | $0 (2024) |
| Mylan Specialty L.P. | $252.25 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,769 | 92 | GlaxoSmithKline, LLC. ($297.38) |
| 2023 | $1,717 | 98 | GlaxoSmithKline, LLC. ($428.64) |
| 2022 | $1,357 | 88 | GlaxoSmithKline, LLC. ($474.97) |
| 2021 | $1,276 | 84 | GlaxoSmithKline, LLC. ($343.97) |
| 2020 | $800.86 | 50 | GlaxoSmithKline, LLC. ($243.98) |
| 2019 | $1,880 | 126 | Boehringer Ingelheim Pharmaceuticals, Inc. ($315.46) |
| 2018 | $1,513 | 108 | GlaxoSmithKline, LLC. ($391.27) |
| 2017 | $1,772 | 118 | Boehringer Ingelheim Pharmaceuticals, Inc. ($485.76) |
All Payment Transactions
764 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $35.54 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: PULMONOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.91 | General |
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.96 | General |
| Category: HFCWO | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.50 | General |
| 11/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/06/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: HFCWO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,248 | 3,548 | $333,067 | $157,511 |
| 2022 | 26 | 1,963 | 3,192 | $280,094 | $137,714 |
| 2021 | 24 | 1,745 | 3,031 | $339,762 | $168,633 |
| 2020 | 24 | 1,947 | 3,573 | $425,800 | $214,127 |
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 374 | $57,222 | $32,654 | 57.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 128 | 288 | $39,456 | $25,957 | 65.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 60 | 129 | $45,924 | $20,985 | 45.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 75 | 75 | $19,575 | $11,528 | 58.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 187 | 359 | $18,668 | $9,646 | 51.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 65 | $11,765 | $8,441 | 71.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 151 | 178 | $17,800 | $6,875 | 38.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 151 | 178 | $17,800 | $5,402 | 30.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 204 | 266 | $15,974 | $5,363 | 33.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 40 | $10,480 | $5,326 | 50.8% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 187 | 359 | $17,950 | $3,649 | 20.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 123 | 126 | $6,048 | $3,010 | 49.8% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 66 | 78 | $11,154 | $2,953 | 26.5% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 109 | 250 | $8,000 | $2,826 | 35.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 23 | 25 | $6,250 | $2,025 | 32.4% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 30 | 31 | $4,650 | $2,024 | 43.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 54 | 54 | $5,346 | $1,459 | 27.3% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 31 | 36 | $5,148 | $1,454 | 28.2% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 118 | 244 | $3,172 | $1,259 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,458 | $951.16 | 65.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 26 | 56 | $952.00 | $764.13 | 80.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 31 | 33 | $2,178 | $749.28 | 34.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 12 | $1,296 | $606.12 | 46.8% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 16 | 18 | $540.00 | $486.90 | 90.2% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 51 | 63 | $1,638 | $412.29 | 25.2% |
About Dr. Caesar Agagan, MD
Dr. Caesar Agagan, MD is a Critical Care Medicine healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285610576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caesar Agagan, MD has received a total of $12,086 in payments from pharmaceutical and medical device companies, with $1,769 received in 2024. These payments were reported across 764 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($11,931).
As a Medicare-enrolled provider, Agagan has provided services to 7,903 Medicare beneficiaries, totaling 13,344 services with total Medicare billing of $677,985. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Mobile, AL
- Active Since 12/19/2005
- Last Updated 06/21/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1285610576
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,502
- OFEV (Drug) $1,176
- NUCALA (Biological) $674.65
- DUPIXENT (Biological) $563.89
- Prolastin-C Liquid (Biological) $545.84
- SMARTVEST (Device) $476.50
- ANORO (Drug) $452.66
- TEZSPIRE (Biological) $397.39
- STIOLTO RESPIMAT (Drug) $386.78
- UPTRAVI (Drug) $334.32
- STIOLTO (Drug) $322.71
- ACTHAR (Biological) $318.94
- LONHALA MAGNAIR (Drug) $293.29
- Xolair (Biological) $257.04
- BREO (Drug) $229.67
- SYMBICORT (Drug) $190.30
- Arikayce (Drug) $177.47
- Prolastin-C (Biological) $159.48
- Esbriet (Biological) $159.23
- FASENRA (Biological) $155.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Mobile
Dr. Adrian Divittorio, Md, MD
Critical Care Medicine — Payments: $118,216
Dr. Peter Lutz, M.d, M.D
Critical Care Medicine — Payments: $58,428
Dr. Philip Almalouf, M.d, M.D
Critical Care Medicine — Payments: $16,158
Campbell Sindel, M.d, M.D
Critical Care Medicine — Payments: $13,968
Dr. Randy Dotson, Md, MD
Critical Care Medicine — Payments: $7,082
Dr. Kewan Hamid, M.d, M.D
Critical Care Medicine — Payments: $6,820